MGC130979 antikoerper, SPTLC2L antikoerper, RGD1310030 antikoerper, C20orf38 antikoerper, LCB2B antikoerper, LCB3 antikoerper, SPT3 antikoerper, dJ718P11 antikoerper, dJ718P11.1 antikoerper, hLCB2b antikoerper, C130053K05Rik antikoerper, serine palmitoyltransferase long chain base subunit 3 antikoerper, serine palmitoyltransferase, long chain base subunit 3 S homeolog antikoerper, serine palmitoyltransferase 3 antikoerper, serine palmitoyltransferase, long chain base subunit 3 antikoerper, SPTLC3 antikoerper, sptlc3.S antikoerper, LOC100438231 antikoerper, sptlc3 antikoerper, LOC100546896 antikoerper, Sptlc3 antikoerper
Hintergrund
Serine palmitoyltransferase (SPT). The heterodimer formed with LCB1/SPTLC1 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC3-SPTSSA isozyme uses both C14-CoA and C16-CoA as substrates, while the SPTLC1-SPTLC3-SPTSSB has the ability to use a broader range of acyl-CoAs without apparent preference.